Fennec Pharmaceuticals Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Fennec Pharma(US:FENC) TMX Newsfile·2026-03-24 17:20San Diego, California--(Newsfile Corp. - March 24, 2026) - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fennec Pharmaceuticals Inc. (NASDAQ: FENC). The investigation focuses on Fennec Pharmaceuticals executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased Fennec Pharmaceuticals securities?If you purchased Fennec Pharmaceuticals securities and suffered losses on your investment, join our investigation now: Click h ...